Status: Not yet recruiting
Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors
This study is being done to test the safety of elraglusib when taken once a day and to assess: * How the body processes the drug (pharmacokinetics) * Assess potential effects of the drug on heart rhythm * Find the highest daily dose that can be given without causing side effects
Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Actuate Therapeutics Inc.Updated: Jul 20, 2026
Eligibility criteria
Able to understand and voluntarily sign a written informed consent and is willin... [+13]
Pregnant or lactating [+21]